J. Tocher

发表

Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases.

J. Tocher, D. I. Edwards, David I. Edwards, 1994, Biochemical pharmacology.

Electrochemical characteristics of nitroheterocyclic compounds of biological interest. V. Measurement and comparison of nitro radical lifetimes.

J. Tocher, D. I. Edwards, 1990, International journal of radiation biology.

Electrochemical characteristics of nitroheterocyclic compounds of biological interest. VI. The misonidazole radical anion.

J. Tocher, D. I. Edwards, 1990, Free radical research communications.

Electrochemical characteristics of nitro-heterocyclic compounds of biological interest. IV. Lifetime of the metronidazole radical anion.

J. Tocher, D. I. Edwards, 1989, Free radical research communications.

Electrochemical and spectroelectrochemical studies on three dinuclear rhodium(II) complexes with O-oxypyridine anions as ligands

D. Tocher, J. Tocher, 1987 .

Synthesis and characterization of Rh2{Ph(2-pyr)N}4: a precursor to a dirhodium(III) dication containing an bond

D. Tocher, J. Tocher, 1986 .

Electrochemical investigations of several transition metal tris(acetylacetonate) complexes

J. Fackler, J. Tocher, 1985 .

Reductive activation of nitroheterocyclic compounds.

J. Tocher, 1997, General pharmacology.

The interaction of nitroaromatic drugs with aminothiols.

J. Tocher, D. I. Edwards, 1995, Biochemical pharmacology.

A model for the proteolytic regulation of LpxC in the lipopolysaccharide pathway of Escherichia coli

Paolo Falcarin, John George, Akintunde Emiola, 2013, Comput. Biol. Chem..

Synthesis and spectroelectrochemical characterisation of a novel rhodium(II) dimer, Rh2(PhNpy)4

D. Tocher, J. Tocher, 1985 .

Structural and electrochemical characterization of the novel ortho-metalated dirhodium(II) compounds Rh2(O2CCH3)2[(C6H5)2P(C6H4)]2•2L

Derek A. Tocher, F. Albert Cotton, F. Cotton, 1985 .

Electrochemical studies on three polar diruthenium(II,III) complexes

F. Cotton, D. Tocher, J. Tocher, 1985 .

SYNTHESES, STRUCTURES AND REDOX PROPERTIES OF TETRAKIS(μ‐BENZAMIDATO)DIRHODIUM(II) COMPLEXES

F. Cotton, D. Tocher, J. Tocher, 1985 .

Mixed-ligand systems containing quadruple bonds. Capture and structural characterization of an intermediate in the ligand exchange process leading to new carboxylates of the dimolybdenum(4+ unit. Synthesis and X-ray crystallographic and electrochemical studies of Mo2[(η5-C5H4CO2)Fe(η5-C5H5)]2(O2CCH3

A. H. Reid, F. Cotton, L. Falvello, 1987 .

Studies on DNA damage and induction of SOS repair by novel multifunctional bioreducible compounds. I. A metronidazole adduct of dirhodium (II) tetraacetate.

J. Tocher, D. I. Edwards, D. Tocher, 1989, Anti-cancer drug design.

Electrochemical investigations of several transition metal tris(acetylacetonate) complexes

J. Fackler, J. Tocher, 1985 .

Experimental and theoretical studies of dinuclear gold(I) and gold(II) phosphorus ylide complexes: oxidative addition, halide exchange, and structural properties including the crystal and molecular structures of [Au(CH2)2PPh2]2 and [Au(CH2)2PPh2]2(CH3)Br

D. Dudis, J. Fackler, D. O. Marler, 1985 .

Experimental and Theoretical Studies of Dinuclear Gold(I) and Gold(II) Phosphorus Ylide Complexes.

D. Dudis, J. Fackler, D. O. Marler, 1986 .

A Vibrational Study by Raman Spectroscopy of Some Dinuclear Gold Ylide Complexes

J. Fackler, R. Clark, J. Tocher, 1986 .

Electrochemical studies of nitroheterocyclic compounds of biological interest. VII. Effect of electrode material.

J. Tocher, D. I. Edwards, D. Tocher, 1991, Free radical research communications.

Electrochemical characteristics of nitro-heterocyclic compounds of biological interest. I. The influence of solvent.

J. Tocher, D. I. Edwards, 1988, Free radical research communications.

Studies on DNA damage and induction of SOS repair by novel multifunctional bioreducible compounds. II. A metronidazole adduct of a ruthenium-arene compound.

J. Tocher, D. I. Edwards, D. Tocher, 1992, Anti-cancer drug design.

Electrochemical characteristics of nitro-heterocyclic compounds of biological interest. II. Nitrosochloramphenicol.

J. Tocher, D. I. Edwards, R. C. Knight, 1989, Free radical research communications.

Effects on DNA of Bioreducible Nitroimidazole and Benzotriazine Drugs

J. Tocher, D. I. Edwards, D. Widdick, 1990 .

DNA damaging effects and voltammetric studies on the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide, SR4233, as a function of pH.

J. Tocher, D. I. Edwards, N. S. Virk, 1990, Biochemical pharmacology.

Electrochemical studies and DNA damaging effects of the benzotriazine-N-oxides.

J. Tocher, D. I. Edwards, N. S. Virk, 1990, Biochemical pharmacology.

Electrochemical properties as a function of pH for the benzotriazine di-N-oxides.

J. Tocher, D. I. Edwards, N. S. Virk, 1990, Free radical research communications.

The interaction of reduced metronidazole with DNA bases and nucleosides.

J. Tocher, D. I. Edwards, 1992, International journal of radiation oncology, biology, physics.

Electrochemical characteristics of nitro-heterocyclic compounds of biological interest. III. Nitroso derivative formation.

J. Tocher, D. I. Edwards, 1989, Free radical research communications.

Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.

G. Adams, I. Stratford, M. Naylor, 1993, Anti-cancer drug design.

The reactivity of chloramphenicol reduction products with DNA bases.

A. Thomas, J. Tocher, D. I. Edwards, 1994, International journal of radiation oncology, biology, physics.